Private NIPT Tests in Cardiff

Private NIPT Tests in Cardiff  (Non-Invasive Prenatal Testing) are highly accurate early pregnancy screening blood tests used to assess the chance of chromosomal conditions such as Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13). It is a safe, non-invasive test that can usually be performed from 10 weeks of pregnancy using a simple maternal blood sample.

NIPT is typically performed as part of first trimester pregnancy care, alongside ultrasound assessment of fetal development, and may also be considered in conjunction with carrier screening where appropriate.

NIPT analyses small fragments of placental DNA (cell-free fetal DNA) circulating in the mother’s blood to estimate the likelihood of certain chromosomal conditions. It is significantly more accurate than traditional screening methods such as the Combined Test and can detect more than 99% of cases of Down syndrome, although performance varies depending on the condition being screened, fetal fraction and the specific test platform used. You can read more in our detailed guide to NIPT testing.

In clinical practice, NIPT is most commonly used as a first-line screening test from 10 weeks of pregnancy, or as a contingent test following a higher-risk Combined Test result. It provides earlier and more accurate risk assessment, allowing patients and clinicians more time to consider further investigations, ongoing monitoring or reassurance.

Different NIPT tests vary in their scope. Standard panels such as the NHS NIPT Test focus on the common trisomies (21, 18 and 13), while more advanced tests may also include sex chromosome conditions (such as Turner syndrome), selected microdeletions (such as 22q11.2 deletion / DiGeorge syndrome) and, in some cases, single gene disorders. The extent of screening and the clinical validation of each panel differs, and this is an important consideration when selecting the most appropriate test.

Choosing between different NIPT panels requires an understanding of both the additional conditions screened and the evidence supporting their performance. While broader panels may appear more comprehensive, not all additional conditions have the same level of validation or predictive value. A targeted approach is often appropriate for many pregnancies, whereas expanded panels may be considered in selected clinical scenarios.

At Innermost Healthcare, we offer a range of advanced NIPT options to suit different clinical needs, from highly validated targeted screening tests to more comprehensive panels. The most appropriate test depends on your individual circumstances, stage of pregnancy, maternal age, ultrasound findings and how much information you would like from your screening. These include Natera Panorama, TDL Veriseq Express, Medicover Veragene, Concepto Absolute and Natera Vistara.

The interpretation of NIPT results should always be considered in the context of the overall clinical picture, including ultrasound findings and maternal factors. For example, a low-risk result does not exclude structural abnormalities, and ultrasound remains essential in identifying anatomical conditions that are not detectable by NIPT.

Although NIPT is highly accurate, it is important to understand that it is a screening test rather than a diagnostic test. A low-chance result is reassuring but does not completely exclude all chromosomal or genetic conditions. Conversely, a high-chance result does not confirm a diagnosis and should be interpreted in the context of ultrasound findings and clinical history.

If a high-chance result is identified, confirmatory diagnostic testing such as chorionic villus sampling (CVS) or amniocentesis may be recommended. These tests provide a definitive diagnosis but are invasive, with a miscarriage risk of approximately 1 in 200. The decision to proceed with diagnostic testing is individual and should be supported by detailed counselling.

It is also important to recognise technical limitations of NIPT, including the possibility of low fetal fraction, confined placental mosaicism, maternal chromosomal variation and other biological factors that may affect results. These factors can occasionally lead to test failure, false positive or false negative results, although this is uncommon.

In most pregnancies, NIPT provides reassurance and reduces the need for invasive testing. However, its greatest value lies in combining high detection rates with low false positive rates, helping to minimise unnecessary procedures while still identifying pregnancies that require further investigation.

Choosing whether to have NIPT, and which test to select, is a personal decision. Our consultant-led service provides clear, evidence-based guidance to help you understand your options, interpret results and decide on the most appropriate next steps for you and your pregnancy.

Book NIPT test UK →